AstraZeneca Introduces Investment of USD2.5 Billion in Beijing

featured-image

(MENAFN) On Friday, British-Swedish pharmaceutical titan AstraZeneca revealed a USD2.5 billion investment in Beijing, reinforcing its dedication to advancing life sciences in China. This significant ...

MENAFN23032025000045017167ID1109346305 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

.